Advertisement

Behaviour Change to Promote Diabetes Outcomes: Getting More From What We Have Through Dissemination and Scalability

Published:September 02, 2022DOI:https://doi.org/10.1016/j.jcjd.2022.08.008

      Abstract

      The potential benefits of advanced medical treatments (pharmacotherapies) and technologies (diagnostics, devices and apps) are unrealized due to lack of sustained behaviour change in individuals living with type 2 diabetes. The lack of scale-up of effective health behaviour change interventions limits health improvement. Identification of mediators of behaviour change (adherence, self-efficacy, intrinsic motivation) can address this limitation by shifting the focus of behaviour change from input (which behaviour change strategy to choose) to output (what can the person adhere to and sustain). Technology and accessing the workplace environment to promote change offer scalable opportunities for facilitating health behaviour change in populations.

      Résumé

      Les avantages potentiels des traitements médicaux avancés (pharmacothérapies) et des technologies (diagnostics, dispositifs et applis) ne se sont pas concrétisés en raison de l’absence de changement durable de comportement chez les individus qui vivent avec le diabète de type 2. L’absence d’élargissement des interventions efficaces de changement de comportement visant à améliorer la santé freine l’amélioration de la santé. L’identification des médiateurs du changement de comportement (observance et adhésion, auto-efficacité, motivation intrinsèque) peut permettre de remédier à cette lacune en privilégiant le changement de comportement du début (quelle stratégie de changement de comportement choisir) à la fin (ce à quoi peut adhérer la personne et le maintenir). Les technologies et l’accès à l’environnement de travail dans le but de promouvoir les changements offrent des occasions évolutives qui favorisent le changement au sein des populations.

      Keywords

      Mots clés

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Canadian Journal of Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • International Diabetes Federation
        Diabetes Atlas. Worldwide toll of diabetes.
        https://diabetesatlas.org/data/en/
        Date: 2021
        Date accessed: September 27, 2022
        • Colosia A.
        • Palencia R.
        • Khan S.
        Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: A systematic literature review.
        Diabetes Metab Syndr Obes Targets Ther. 2013; 6: 327-338
        • Khunti K.
        • Ceriello A.
        • Cos X.
        • De Block C.
        Achievement of guideline targets for blood pressure, lipid, and glycaemic control in type 2 diabetes: A meta-analysis.
        Diabetes Res Clin Pract. 2018; 137: 137-148
        • Tamblyn R.
        • Eguale T.
        • Huang A.
        • Winslade N.
        • Doran P.
        The incidence and determinants of primary nonadherence with prescribed medication in primary care: A cohort study.
        Ann Intern Med. 2014; 160: 441-450
        • Campbell D.J.T.
        • Campbell D.B.
        • Ogundeji Y.
        • et al.
        First-line pharmacotherapy for incident type 2 diabetes: Prescription patterns, adherence and associated costs.
        Diabet Med. 2021; 38e14622
        • Roussel R.
        • Charbonnel B.
        • Behar M.
        • Gourmelen J.
        • Emery C.
        • Detournay B.
        Persistence with insulin therapy in patients with type 2 diabetes in France: An insurance claims study.
        Diabetes Ther Res Treat Educ Diabetes Relat Disord. 2016; 7: 537-549
        • Yeaw J.
        • Benner J.S.
        • Walt J.G.
        • Sian S.
        • Smith D.B.
        Comparing adherence and persistence across 6 chronic medication classes.
        J Manag Care Pharm. 2009; 15: 728-740
        • Bailey R.R.
        • Phad A.
        • McGrath R.
        • Haire-Joshu D.
        Prevalence of five lifestyle risk factors among U.S. adults with and without stroke.
        Disabil Health J. 2019; 12: 323-327
        • Mokdad A.H.
        • Ballestros K.
        • Echko M.
        • et al.
        • US Burden of Disease Collaborators
        The state of US Health, 1990–2016: Burden of diseases, injuries, and risk factors among US states.
        JAMA. 2018; 319: 1444-1472
        • Tamakoshi A.
        • Tamakoshi K.
        • Lin Y.
        • et al.
        Healthy lifestyle and preventable death: Findings from the Japan Collaborative Cohort (JACC) study.
        Prev Med. 2009; 48: 486-492
        • King D.E.
        • Mainous 3rd, A.G.
        • Geesey M.E.
        Turning back the clock: Adopting a healthy lifestyle in middle age.
        Am J Med. 2007; 120: 598-603
        • Diabetes Prevention Program Research Group
        Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.
        N Engl J Med. 2002; 346: 393-403
        • Look AHEAD Research Group
        Eight-year weight losses with an intensive lifestyle intervention: The look AHEAD study.
        Obes Silver Spring Md. 2014; 22: 5-13
        • Lean M.E.
        • Leslie W.S.
        • Barnes A.C.
        • et al.
        Primary care-led weight management for remission of type 2 diabetes (DiRECT): An open-label, cluster-randomised trial.
        Lancet. 2018; 391: 541-551
        • Lean M.E.J.
        • Leslie W.S.
        • Barnes A.C.
        • et al.
        Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial.
        Lancet Diabetes Endocrinol. 2019; 7: 344-355
        • Cradock K.A.
        • ÓLaighin G.
        • Finucane F.M.
        • Gainforth H.L.
        • Quinlan L.R.
        • Ginis K.A.M.
        Behaviour change techniques targeting both diet and physical activity in type 2 diabetes: A systematic review and meta-analysis.
        Int J Behav Nutr Phys Act. 2017; 14: 18
        • Cradock K.A.
        • ÓLaighin G.
        • Finucane F.M.
        • et al.
        Diet behavior change techniques in type 2 diabetes: A systematic review and meta-analysis.
        Diabetes Care. 2017; 40: 1800-1810
        • Nichols J.
        • Vallis M.
        • Boutette S.
        • Gall Casey C.
        • Yu C.H.
        A Canadian cross-sectional survey on psychosocial supports for adults living with type 1 or 2 diabetes: Health-care providers’ awareness, capacity and motivation.
        Can J Diabetes. 2018; 42 (389–94.e2)
        • Stuckey H.L.
        • Vallis M.
        • Kovacs Burns K.
        • et al.
        “I do my best to listen to patients”: Qualitative Insights Into DAWN2 (Diabetes Psychosocial Care From the Perspective of Health Care Professionals in the Second Diabetes Attitudes, Wishes and Needs Study).
        Clin Ther. 2015; 37 (1986–98.e12)
        • Shah M.K.
        • Moore M.A.
        • Narayan K.M.V.
        • Ali M.K.
        Trends in lifestyle counseling for adults with and without diabetes in the U.S., 2005–2015.
        Am J Prev Med. 2019; 57: e153-e161
        • Song Z.
        • Baicker K.
        Effect of a workplace wellness program on employee health and economic outcomes: A randomized clinical trial.
        JAMA. 2019; 321: 1491-1501
        • Ismail K.
        • Stahl D.
        • Bayley A.
        • et al.
        Enhanced motivational interviewing for reducing weight and increasing physical activity in adults with high cardiovascular risk: The MOVE IT three-arm RCT.
        Health Technol Assess Winch Engl. 2019; 23: 1-144
        • Perepletchikova F.
        • Kazdin A.E.
        Treatment integrity and therapeutic change: Issues and research recommendations.
        Clin Psychol Sci Pract. 2005; 12: 365-383
        • Vallis M.
        Are behavioural interventions doomed to fail? Challenges to self-management support in chronic diseases.
        Can J Diabetes. 2015; 39: 330-334
        • Vallis M.
        Behaviour change counselling: How do I know if I am doing it well? The development of the Behaviour Change Counselling Scale (BCCS).
        Can J Diabetes. 2013; 37: 18-26
        • Vallis M.
        • Lee-Baggley D.
        • Sampalli T.
        • et al.
        Equipping providers with principles, knowledge and skills to successfully integrate behaviour change counselling into practice: A primary healthcare framework.
        Public Health. 2018; 154: 70-78
        • Vallis M.
        • Lee-Baggley D.
        • Sampalli T.
        • et al.
        Integrating behaviour change counselling into chronic disease management: A square peg in a round hole? A system-level exploration in primary health care.
        Public Health. 2019; 175: 43-53
        • Wharton S.
        • Lau D.C.W.
        • Vallis M.
        • et al.
        Obesity in adults: Aa clinical practice guideline.
        CMAJ. 2020; 192: E875-E891
        • Vallis M.
        • Macklin D.
        • Russell-Mayhew S.
        Canadian adult obesity clinical practice guidelines: Effective psychological and behavioural interventions in obesity management.
        https://obesitycanada.ca/guidelines/behavioural
        Date: 2020
        Date accessed: September 27, 2022
        • Middleton K.R.
        • Anton S.D.
        • Perri M.G.
        Long-term adherence to health behavior change.
        Am J Lifestyle Med. 2013; 7: 395-404
        • Vallis M.
        Psychological traps in diabetes management: To be forewarned is to be forearmed.
        Can J Diabetes. 2001; 25: 31-38
        • Abraham C.
        • Michie S.
        A taxonomy of behavior change techniques used in interventions.
        Health Psychol. 2008; 27: 379-387
        • Michie S.
        • van Stralen M.M.
        • West R.
        The behaviour change wheel: A new method for characterising and designing behaviour change interventions.
        Implement Sci. 2011; 23: 42
        • Jackson C.
        • Eliasson Â.L.
        • Barber N.
        • Weinman J.
        Applying COM-B to medication adherence: A suggested framework for research and interventions.
        Eur Health Psychol. 2014; 16: 7-17
        • Beck A.T.
        A 60-year evolution of cognitive theory and therapy.
        Perspect Psychol Sci J Assoc Psychol Sci. 2019; 14: 16-20
        • Veit C.T.
        • Ware Jr., J.E.
        The structure of psychological distress and well-being in general populations.
        J Consult Clin Psychol. 1983; 51: 730-742
        • Robinson D.J.
        • Coons M.J.
        • Haensel H.
        • Vallis M.
        • Yale J.F.
        Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada: Diabetes and mental health.
        Can J Diabetes. 2018; 4: S1-S325
        • Epstein L.
        • Ogden J.
        A qualitative study of GPs’ views of treating obesity.
        Br J Gen Pract. 2005; 55: 750-754
        • Wu X.
        • Guo X.
        • Zhang Z.
        The efficacy of mobile phone apps for lifestyle modification in diabetes: Systematic review and meta-analysis.
        JMIR mHealth uHealth. 2019; 7e12297
      1. Diabetes Canada. Diabetes rates continue to climb in Canada.
        (Accessed July, 2022.)